Williamson Legacy Group LLC Purchases 1,001 Shares of Aflac Incorporated $AFL

Williamson Legacy Group LLC grew its holdings in shares of Aflac Incorporated (NYSE:AFL) by 21.1% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,738 shares of the financial services provider’s stock after buying an additional 1,001 shares during the quarter. Williamson Legacy Group LLC’s holdings in Aflac were worth $605,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of AFL. Brighton Jones LLC increased its stake in Aflac by 64.4% in the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 5,708 shares during the period. Bison Wealth LLC grew its holdings in shares of Aflac by 4.3% in the fourth quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider’s stock worth $455,000 after purchasing an additional 183 shares during the last quarter. Mackenzie Financial Corp increased its stake in Aflac by 7.5% in the 1st quarter. Mackenzie Financial Corp now owns 74,764 shares of the financial services provider’s stock worth $8,313,000 after buying an additional 5,203 shares during the period. Meeder Asset Management Inc. lifted its holdings in Aflac by 90.8% during the 1st quarter. Meeder Asset Management Inc. now owns 330 shares of the financial services provider’s stock valued at $37,000 after buying an additional 157 shares in the last quarter. Finally, Banque Cantonale Vaudoise bought a new stake in Aflac during the 1st quarter valued at about $1,087,000. 67.44% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP Audrey B. Tillman sold 15,862 shares of Aflac stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $112.00, for a total value of $1,776,544.00. Following the transaction, the executive vice president owned 230,688 shares of the company’s stock, valued at $25,837,056. The trade was a 6.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Joseph L. Moskowitz sold 786 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $113.75, for a total transaction of $89,407.50. Following the sale, the director directly owned 24,829 shares of the company’s stock, valued at $2,824,298.75. The trade was a 3.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 22,822 shares of company stock worth $2,571,002. Corporate insiders own 0.90% of the company’s stock.

Aflac Stock Down 0.2%

Aflac stock opened at $110.31 on Friday. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33. The firm has a market cap of $57.82 billion, a P/E ratio of 25.01, a P/E/G ratio of 2.93 and a beta of 0.83. The business has a fifty day moving average of $110.31 and a two-hundred day moving average of $106.27. Aflac Incorporated has a twelve month low of $96.95 and a twelve month high of $115.83.

Aflac (NYSE:AFL) last released its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 EPS for the quarter. The firm had revenue of $5.91 billion during the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%. On average, analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac announced that its board has authorized a share buyback program on Tuesday, August 12th that allows the company to repurchase 100,000,000 shares. This repurchase authorization allows the financial services provider to buy shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

Aflac Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Wednesday, February 18th will be issued a $0.61 dividend. The ex-dividend date is Wednesday, February 18th. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.2%. This is an increase from Aflac’s previous quarterly dividend of $0.58. Aflac’s dividend payout ratio (DPR) is 31.85%.

Analysts Set New Price Targets

A number of equities analysts have commented on AFL shares. Wells Fargo & Company upped their target price on shares of Aflac from $107.00 to $109.00 and gave the stock an “equal weight” rating in a research note on Friday, November 7th. Evercore ISI increased their price objective on Aflac from $110.00 to $111.00 and gave the stock an “underperform” rating in a research note on Friday, November 7th. Weiss Ratings restated a “buy (b)” rating on shares of Aflac in a report on Tuesday. Keefe, Bruyette & Woods upped their target price on Aflac from $108.00 to $110.00 and gave the stock a “market perform” rating in a report on Thursday, October 9th. Finally, Barclays reissued an “underweight” rating and set a $104.00 price target (up previously from $102.00) on shares of Aflac in a research report on Wednesday, November 5th. Three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Aflac currently has an average rating of “Hold” and a consensus price target of $111.00.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.